StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Announces EU Approval of Biosimilar TRAZIMERA
July 31, 2018 6:10 AM
Pfizer Inc. (NYSE: PFE) today announced the European Commission (EC) has approved TRAZIMERA™,1 a biosimilar to Herceptin®* (trastuzumab), for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Next Articles
Pfizer (PFE) Reports Marketing Authorization in European Union from Euro Commission for Moderately to Severely Active Ulcerative Colitis
August 1, 2018 6:30 AM
Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)
July 31, 2018 6:00 AM